prikaz prve stranice dokumenta Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia
Pristup korisnicima matične ustanove
Znanstveni rad - Izvorni znanstveni rad
Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia
Human Psychopharmacology: Clinical and Experimental, 36 (2020); e2763. https://doi.org/10.1002/hup.2763
Karlović, Dalibor; Silić, Ante; Crnković, Danijel; Peitl, Vjekoslav

Citirajte ovaj rad

Karlović, D., Silić, A., Crnković, D. i Peitl, V. (2020). Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia. Human Psychopharmacology: Clinical and Experimental, 36.. doi: 10.1002/hup.2763

Karlović, Dalibor, et al. "Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia." Human Psychopharmacology: Clinical and Experimental, vol. 36, 2020. https://doi.org/10.1002/hup.2763

Karlović, Dalibor, Ante Silić, Danijel Crnković i Vjekoslav Peitl. "Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia." Human Psychopharmacology: Clinical and Experimental 36 (2020). https://doi.org/10.1002/hup.2763

Karlović, D., et al. (2020) 'Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia', Human Psychopharmacology: Clinical and Experimental, 36. doi: 10.1002/hup.2763

Karlović D, Silić A, Crnković D, Peitl V. Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia. Human Psychopharmacology: Clinical and Experimental [Internet]. 2020. [pristupljeno 28.10.2024.];36. doi: 10.1002/hup.2763

D. Karlović, A. Silić, D. Crnković i V. Peitl, "Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia", Human Psychopharmacology: Clinical and Experimental, vol. 36, 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:220:526967. [Citirano: 28.10.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:220:526967
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Effects of aripiprazole long‐acting injectable antipsychotic on hospitalization in recent‐onset schizophrenia
AutorDalibor Karlović
AutorAnte Silić
AutorDanijel Crnković
AutorVjekoslav Peitl
Autorova ustanova(Klinički bolnički centar Sestre milosrdnice)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Psihijatrija
Sažetak (engleski)
Objective: Recent‐onset schizophrenia (ROS) represents a critical period that can greatly influence the clinical course of schizophrenia. The use of long‐acting injectable antipsychotics (LAIs) in this period is increasingly being considered as a first‐line treatment option. Aripiprazole LAI (ALAI) is the newest of all LAI's available on the market, with limited data on its effects on hospitalization rates after first episode of schizophrenia. It was our goal to evaluate whether ALAI has an effect on hospitalization rates, number of bed days and clinical improvement in patients with ROS. Methods: This mirror‐image study included 138 inpatients suffering from schizophrenia. We collected sociodemographic data on all individuals, number of hospitalization days, hospitalization rates as well as Clinical Global Impression Scale—severity of illness (CGI‐S) and Clinician‐Rated Dimensions of Psychosis Symptom Severity (CRDPSS) scores at the initiation of ALAI and at the end of a 1 year follow up. Results: Mean number of hospitalizations and hospitalization days in the year after starting ALAI significantly decreased compared to the year before (p ¼ 0.005 and p < 0.001). Mean scores on both CGI and CRDPSS also significantly decreased after initiating ALAI (p < 0.001). Conclusion: Results suggest that ALAI is an important therapeutic option in patients with ROS. It leads to reduced usage of hospital services, potentially reducing the socio‐economic healthcare burden.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaHuman Psychopharmacology: Clinical and Experimental
Brojčani podacivol. 36, e2763
p-ISSN0885-6222
e-ISSN1099-1077
DOIhttps://doi.org/10.1002/hup.2763
URN:NBNurn:nbn:hr:220:526967
Datum objave publikacije2020
URL dokumentahttps://onlinelibrary.wiley.com/doi/10.1002/hup.2763
Vrsta resursaTekst
Prava pristupaInstitucijski pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2023-09-29 08:17:19